Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus

Journal of Cardiovascular Magnetic Resonance

Volumn 16, Issue 1, 2014, Pages

  Hall, Michael E ^a   Rocco, Michael V ^b   Morgan, Timothy M ^b   Hamilton, Craig A ^b   Edwards, Matthew S ^b   Jordan, Jennifer H ^b   Hurie, Justin B ^b   Hundley, W Gregory ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Furosemide; Oxygenation; Renal artery stenosis; Renal BOLD

Indexed keywords

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; AGED; BIOLOGICAL MARKERS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FUROSEMIDE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; RENAL CIRCULATION; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 84893833035     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-16-17     Document Type: Article

References (27)

1. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. Textor S, Glockner J, Lerman L, Misra S, McKusick MA, Reiderer SJ, Grade JP, Gomez SI, Romero JC, J Am Soc Nephrol 2008 19 780 8 10.1681/ASN.2007040420 18287564
2. Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Gloviczki ML, Glockner JF, Lerman LO, McKusick MA, Mistra S, Grande JP, Textor SC, Hypertension 2010 55 961 6 10.1161/HYPERTENSIONAHA.109.145227 20194303
3. Blockade of the renin-angiotensin system and renal tissue oxygenation as measured with BOLD-MRI in patients with type 2 diabetes. Pruijim M, Hofmann L, Zanchi A, Maillard M, Forni V, Muller ME, Wuezner G, Vogt B, Stuber M, Burnier M, Diabetes Res Clin Pract 2013 99 136 44 10.1016/j.diabres.2012.11.004 23245807
4. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ann Intern Med 2009 150 604 12 10.7326/0003-4819-150-9-200905050- 00006 19414839
5. Magnetic resonance imaging assessment of the severity of mitral regurgitation: comparison of invasive techniques. Hundley WG, Li F, Willard JE, Landau C, Lange RA, Meshack BM, Hillis LD, Peshock RM, Circulation 1995 92 1151 8 10.1161/01.CIR.92.5.1151 7648660
6. Comparison of 1.5 and 3T BOLD MR to study oxygenation of kidney cortex and medulla in human renovascular disease. Gloviczki ML, Glockner J, Gomez SI, Romero JC, Lerman LO, McKusick M, Textor SC, Invest Radiol 2009 44 566 71 10.1097/RLI.0b013e3181b4c1e8 19668000
7. New insights into the epidemiologic and clinical manifestations of atherosclerotic renovascular disease. Conlon PJ, O'Riordan E, Kalra PA, Amer J of Kidney Dis 2000 35 573 87 10.1016/S0272-6386(00)70002-3 (Pubitemid 30185500)
8. Prospective study of atherosclerotic disease progression in the renal artery. Caps MT, Perissinotto C, Zierler R, Polissar NL, Bergelin RO, Tullis MJ, Cantwell-Gab K, Davidson RC, Strandness DE Jr, Circulation 1998 98 2866 10.1161/01.CIR.98.25.2866 9860789
9. Atherosclerotic renal artery stenosis: overtreated but underrated? Textor SC, J Am Soc Nephrol 2008 19 656 9 10.1681/ASN.2007111204 18235081
10. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B, J Am Coll Cardiol 2006 47 1239 312 10.1016/j.jacc.2005.10.009 16545667
11. Blood oxygen level-dependent (BOLD) MRI in renovascular hypertension. Gloviczki ML, Lerman LO, Textor SC, Curr Hypertens Rep 2011 13 370 7 10.1007/s11906-011-0218-7 21833688
12. Site and mechanism of action of diuretics. Kokko JP, Am J Med 1984 77 11 7 10.1016/S0002-9343(84)80003-0 (Pubitemid 15222751)
13. Characterization of Na+ transport across the cell membranes of the ascending thin limb of Henle's loop. Takahashi N, Kondo Y, Fujiwara I, Ito O, Igarashi Y, Abe K, Kidney Int 1995 47 789 94 10.1038/ki.1995.120 7752578
14. Sodium-chloride transport in the thick ascending limb of Henle's loop. Oxygen consumption studies in isolated cells. Eveloff J, Bayerdorffer E, Silva P, Kinne R, Pflugers Arch 1981 389 263 70 10.1007/BF00584788 6262707 (Pubitemid 11150178)
15. The site of action of furosemide and other sulfonamide diuretics in the dog. Suki W, Rector FC, Seldin DW, J Clin Invest 1965 44 1458 69 10.1172/JCI105252 14332159
16. Determinants of intrarenal oxygenation. Effects of diuretics. Brezis M, Agmon Y, Epstein FH, Am J Physiol 1994 267 1059 62 7810692
17. Association of filtered sodium load with medullary volumes and medullary hypoxia in hypertensive African Americans as compared with whites. Textor SC, Gloviczki ML, Flessner MF, Calhoun DA, Glockner J, Grande JP, McKusick MA, Cha SS, Lerman LO, Am J Kidney Dis 2012 59 229 37 10.1053/j.ajkd.2011.09.023 22130642
18. Determinants of intrarenal oxygenation. II. Hemodynamic effects. Brezis M, Heyman SN, Epstein FH, Am J Physiol 1994 267 1063 8 7810693
19. Factors that render the kidney susceptible to tissue hypoxia in hypoxemia. Evans RG, Goddard D, Eppel GA, O'Connor PM, Am J Physiol Regul Integr Comp Physiol 2011 300 931 40 10.1152/ajpregu.00552.2010 21248306
20. Nephrogenic systemic fibrosis and class labeling of gadolinium-based contrast agents by the food and Drug Administration. Yang L, Krefting I, Gorovets A, Marzella L, Kaiser J, Boucher R, Rieves D, Radiology 2012 265 248 53 10.1148/radiol.12112783 22923714
21. Vascular effects of loop diuretics. Dormans T, Pickkers P, Russel F, Smits P, Cardiovasc Res 1996 32 988 97 10.1016/S0008-6363(96)00134-4 9015400 (Pubitemid 26423386)
22. Hypoxia of the renal medulla: its implications for disease. Brezis M, Rosen S, N Engl J Med 1995 332 647 55 10.1056/NEJM199503093321006 7845430
23. Renal oxygen delivery: matching delivery to metabolic demand. O'Connor PM, Clin Exp Pharmacol Physiol 2006 33 961 7 10.1111/j.1440-1681.2006.04475.x 17002675 (Pubitemid 44427321)
24. Oxygen and renal metabolism. Epstein FH, Kidney Int 1997 51 381 5 10.1038/ki.1997.50 9027710 (Pubitemid 27088147)
25. Intrarenal oxygenation: unique challenges and the biophysical basis of homeostasis. Evans RG, Gardiner BS, Smith DW, O'Connor PM, Am J Physiol Regul Integr Comp Physiol 2008 295 1259 70
26. Regulation of oxygen utilization by angiotensin in chronic kidney disease. Deng A, Tang T, Singh P, Satriano J, Thomson SC, Blantz RC, Kidney Int 2009 75 197 204 10.1038/ki.2008.481 18818681
27. Renal BOLD-MRI does not reflect renal function in chronic kidney disease. Michaely HJ, Metzger L, Haneder, Hansmann J, Schoenberg SO, Attenberger UI, Kidney Int 2012 81 684 9 10.1038/ki.2011.455 22237750